美国 - 英文 - NLM (National Library of Medicine)

pain & stress center products - 5-methoxytryptamine (unii: 3vmw6141kc) (5-methoxytryptamine - unii:3vmw6141kc), acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x), dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x), .gamma.-aminobutyric acid (unii: 2acz6ipc6i) (.gamma.-aminobutyric acid - unii:2acz6ipc6i), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j), melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5 - 5-methoxytryptamine 12 [hp_x] in 1 ml - may temporarily increase serotonin, gaba, dopa, and other neurotransmitters in the body and brain for calmness, relaxation, and control. neuro links contains a complex of neurotransmitters found in the brain and body.  use neuro links in conjunction with amino acids to boost your neurotransmitters. may temporarily increase serotonin, gaba, dopa, and other neurotransmitters in the body and brain for calmness, relaxation, and control. neuro links contains a complex of neurotransmitters found in the brain and body. use neuro links in conjunction with amino acids to boost your neurotransmitters.

美国 - 英文 - NLM (National Library of Medicine)

restivo chiropractic - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), dopamine hydrochloride (unii: 7l3e358n9l) (dopamine - unii:vtd58h1z2x), .gamma.-aminobutyric acid (unii: 2acz6ipc6i) (.gamma.-aminobutyric acid - unii:2acz6ipc6i), norepinephrine (unii: x4w3enh1cv) (norepinephrine - unii:x4w3enh1cv), octopamine (unii: 14o50ws8jd) (octopamine - unii:14o50ws8jd), serotonin hydrochloride (unii: gkn429m9vs) (serotonin - unii:333do1rdjy), t - for the temporary relief of symptoms relating to sleep, emotional, nervous or memory disorders.   for the temporary relief of symptoms relating to sleep, emotional, nervous or memory disorders.  

美国 - 英文 - NLM (National Library of Medicine)

the wellness center for reseach and education, inc. - .gamma.-aminobutyric acid (unii: 2acz6ipc6i) (.gamma.-aminobutyric acid - unii:2acz6ipc6i), glutamic acid (unii: 3kx376gy7l) (glutamic acid - unii:3kx376gy7l), norepinephrine bitartrate (unii: ify5pe3zrw) (norepinephrine - unii:x4w3enh1cv), acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x), levodopa (unii: 46627o600j) (levodopa - unii:46627o600j), serotonin hydrochloride (unii: gkn429m9vs) (serotonin - unii:333do1rdjy), thyroid, porcine (unii: 6rv024oauq) (sus scrofa thyroid - for the temporary relief of loss of memory, metal weakness, senile dementia, forgetfulness, confusion, anxiety, brain fog, children with slow mental and physical development. for the temporary relief of loss of memory, metal weakness, senile dementia, forgetfulness, confusion, anxiety, brain fog, children with slow mental and physical development.

美国 - 英文 - NLM (National Library of Medicine)

energique,inc. - (in each spray): 6.66% of agnus castus 12x, avena sativa 6x, damiana 12x, epimedium grandiflorum 30c, ginkgo biloba 12x, hepar suis 6x, human growth hormone 26x, hypothalamus (suis) 12x, lycopodium clabatum 12x, orchitinum (suis) 6x, serotonin (hydrochloride) 30c, 0.10% of testosterone 6x. - for temporary relief of sexual debility from nervous prostration, for enhancing sexual function, nervous exhaustion causing lack of sexual desire.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. for temporary relief of sexual debility from nervous prostration, for enhancing sexual function, nervous exhaustion causing lack of sexual desire.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

美国 - 英文 - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185 or visiting online at https://wo

美国 - 英文 - NLM (National Library of Medicine)

golden state medical supply, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions ( 5.2), drug interactions ( 7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405- 6185 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/ risk summary published prospective cohort studies, case series, and case reports over several decades with trazodone use in p

美国 - 英文 - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets usp are indicated for the treatment of major depressive disorder (mdd) in adults. the efficacy of trazodone hydrochloride tablets usp has been established in trials with the immediate release formulation of trazodone [see clinical studies (14)]. none. teratogenic effects pregnancy category c trazodone hydrochloride has been shown to cause increased fetal resorption and other adverse effects on the fetus in two studies using the rat when given at dose levels approximately 30 to 50 times the proposed maximum human dose. there was also an increase in congenital anomalies in one of three rabbit studies at approximately 15 to 50 times the maximum human dose. there are no adequate and well-controlled studies in pregnant women. trazodone hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. trazodone and/or its metabolites have been found in the milk of lactating rats, suggesting that the drug may be secreted in human mi

美国 - 英文 - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 300 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405- 6185 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/. risk summary published prospective cohort studies, case series, and case reports over several decades with trazodone use in pregnant women have not identified any drug-associate

美国 - 英文 - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. the efficacy of trazodone hydrochloride tablets has been established in trials with the immediate release formulation of trazodone [see clinical studies ( 14)]. none. teratogenic effects pregnancy category c trazodone hydrochloride has been shown to cause increased fetal resorption and other adverse effects on the fetus in two studies using the rat when given at dose levels approximately 30 to 50 times the proposed maximum human dose. there was also an increase in congenital anomalies in one of three rabbit studies at approximately 15 to 50 times the maximum human dose. there are no adequate and well-controlled studies in pregnant women. trazodone hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. trazodone and/or its metabolites have been found in the milk of lactating rats, suggesting that the drug may be

美国 - 英文 - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - trazodone hydrochloride (unii: 6e8zo8lrnm) (trazodone - unii:ybk48bxk30) - trazodone hydrochloride 50 mg - trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd) in adults. trazodone hydrochloride tablets are contraindicated in: - patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (maois), including maois such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185 or visiting online at https://wome